Risk group directs treatment
Grade Group, PSA, tumor stage, MRI, cores, and spread determine whether surveillance, surgery, radiation, or systemic treatment is reasonable.
Prostate cancer treatment cost in Thailand
A prostate cancer estimate should begin with PSA, multiparametric MRI, biopsy grade and cores, clinical stage, lymph-node or bone findings, life expectancy, urinary function, sexual priorities, and the patient’s goals. Thailand can offer surgery, image-guided radiation, brachytherapy, hormone treatment, chemotherapy, and newer systemic care, but the quote must show whether it is for localized cure, recurrence control, or metastatic disease and how follow-up will continue at home.
How much does prostate cancer treatment cost in Thailand?
Localized prostatectomy in Thailand may be budgeted at THB 495,000 to 1,155,000, about USD 15,000 to 35,000, when the case has a defined surgical plan and routine admission. Radiation with hormone treatment and follow-up may range from THB 825,000 to 2,310,000, around USD 25,000 to 70,000. Metastatic or recurrent disease using long-term hormone therapy, chemotherapy, radioligand or newer medicines can reach THB 1,320,000 to 4,950,000+, roughly USD 40,000 to 150,000+. The treating team must convert the estimate into a patient-specific plan.
USD illustrations use approximately THB 33 per USD, based on the Bank of Thailand exchange-rate context checked in July 2026. Drug, implant, radiation, and robotic-system quotes may use different currencies. Ask which currency controls the deposit, medicine supply, exchange adjustment, and final bill.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-19
Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team
Billing context: THB and USD
Grade Group, PSA, tumor stage, MRI, cores, and spread determine whether surveillance, surgery, radiation, or systemic treatment is reasonable.
Urinary continence, erections, bowel effects, fertility, and testosterone recovery should be discussed before choosing a route.
Robotic surgery may change access and recovery but does not remove cancer, urinary, sexual, bleeding, or anesthesia risks.
Injections or tablets may continue for months or years and require metabolic, bone, cardiovascular, and symptom monitoring.
A successful trip includes a PSA schedule, pathology report, treatment summary, and an identified urologist or oncologist at home.
Cost at a glance
The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.
| Scenario | THB | USD | Patient and treatment context | Planning scope |
|---|---|---|---|---|
| Localized surgery pathway | THB 495,000 - 1,155,000 | USD 15,000 - 35,000 | Biopsy-confirmed localized disease proceeding to open, laparoscopic, or robotic prostatectomy with routine lymph-node assessment where indicated. | Name MRI review, surgeon, anesthesia, robotic or laparoscopic system, pathology, room, catheter, continence teaching, and early review. |
| Radiation and hormone pathway | THB 825,000 - 2,310,000 | USD 25,000 - 70,000 | Intermediate or high-risk localized or locally advanced disease treated with external radiation, brachytherapy, hormone treatment, or a combination. | Include planning, image guidance, fractions or implants, hormone injections or tablets, blood tests, side-effect review, and duration. |
| Recurrent or metastatic care | THB 1,320,000 - 4,950,000+ | USD 40,000 - 150,000+ | Biochemical recurrence, metastatic hormone-sensitive disease, castration-resistant cancer, painful bone disease, or long-term systemic treatment. | Budget by named medicine, scan schedule, bone protection, chemotherapy or radioligand access, and response-dependent continuation. |
Usually included
PSA history, MRI, biopsy, grade group, stage, urinary and sexual function, comorbidities, and treatment goals are reviewed.
Send pathology and MRI source data before travel.
Prostatectomy, radiation, brachytherapy, or focal treatment only when the exact procedure and equipment are named.
Robotic, navigation, implant, and image-guidance assumptions need writing.
Hormone injection, tablet, chemotherapy, bone medicine, or another named treatment with dose and interval.
A first injection is not a full hormone course.
Catheter or bowel instructions, pathology, medicine plan, PSA dates, pelvic-floor advice, and home clinician communication.
Sexual and continence rehabilitation may be separate.
Confirm separately
Repeat MRI, PSMA PET, outside slide review, genomic testing, node pathology, or additional biopsy.
Confirm which test changes management.
Robotic consumables, brachytherapy seeds, spacer, fiducials, specialized radiation, penile prosthesis, or urinary device unless stated.
Device brand and warranty should be visible.
Hormone injections, anti-androgens, chemotherapy, steroids, bone agents, pain medicines, and treatment for side effects.
Ask for a monthly or cycle-based forecast.
Bleeding, infection, leak, clot, retention, incontinence, erectile treatment, bowel injury, fracture, admission, and hotel extension.
Keep a reserve for delayed recovery.
Candidate context
The treatment decision should follow life expectancy, overall health, PSA trend, MRI, biopsy grade group, tumor volume, local extension, lymph nodes, bone or visceral spread, urinary baseline, sexual priorities, fertility, and willingness to complete surveillance. Active surveillance can be appropriate for selected lower-risk disease. Surgery or radiation may be curative for localized disease. Hormone treatment, chemotherapy, radioligand treatment, targeted medicine, and bone protection may be used when disease has returned or spread. Thailand should be considered only after a named urology-oncology team reviews the complete record.
Biopsy grade, positive cores, PSA density, MRI lesion, clinical stage, and selected genomic evidence help separate low, intermediate, and high risk.
Heart, lungs, kidney function, obesity, anticoagulation, prior pelvic surgery, bowel disease, and anesthesia risk affect prostatectomy.
Urinary symptoms, prostate size, prior pelvic radiation, bowel disease, hip hardware, and ability to attend planned sessions influence the choice.
PSMA PET, CT, MRI, bone imaging, symptoms, alkaline phosphatase, and organ function may be needed before systemic care.
Continence, erections, fertility, bowel function, work, exercise, and long-term medicine access should be in the care plan.
Selected lower-risk patients may monitor PSA, MRI, examination, and repeat biopsy instead of immediate treatment.
Open, laparoscopic, or robotic removal may be used for selected localized disease with pelvic-node assessment when indicated.
External-beam, stereotactic, or implant radiation can be chosen according to risk, anatomy, urinary function, and local expertise.
Androgen-deprivation, androgen-receptor medicines, chemotherapy, bone treatment, and selected advanced therapies can control recurrent or metastatic disease.
Procedure variations
Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.
Minimally invasive removal with pelvic reconstruction and possible node dissection.
Ask about surgeon volume, conversion, catheter duration, pathology, and continence pathway.
Precisely planned fractions treat the prostate and selected nodes over a schedule set by risk.
Planning, image guidance, fractions, and bowel or bladder support must be priced.
Radioactive seeds or a temporary source delivers treatment inside or near the prostate.
Include anesthesia, implants, urinary monitoring, and radiation-safety instructions.
Androgen deprivation may start before, continue during, and follow radiation.
State injection, tablet, interval, months, bone, metabolic, and cardiovascular monitoring.
Hormone-sensitive or resistant disease may need layered medicines, chemotherapy, bone agents, or another specialist treatment.
Progression can change the drug and budget.
City comparison
Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.
| City | Local range | USD range | Capability context | Stay planning |
|---|---|---|---|---|
| Bangkok | THB 561,000 - 4,950,000+ | USD 17,000 - 150,000+ | Broad access to robotic urology, radiation planning, nuclear medicine, pathology, and medical oncology. | Confirm PSMA PET, brachytherapy, named surgeon, medicine stock, and home PSA handover. |
| Chiang Mai | THB 528,000 - 4,290,000+ | USD 16,000 - 130,000+ | University and private services may offer prostate surgery, radiation, and systemic follow-up. | Check advanced imaging and escalation arrangements for recurrence or complications. |
| Phuket | THB 561,000 - 4,125,000+ | USD 17,000 - 125,000+ | International coordination is strong, with specialist depth dependent on the named hospital. | Do not select a resort location before confirming urology and oncology capability. |
| Pattaya and Chon Buri | THB 528,000 - 3,795,000+ | USD 16,000 - 115,000+ | Selected eastern hospitals provide urology, radiation, or medicine services. | Verify whether complex surgery and radiation happen locally or require Bangkok travel. |
| Khon Kaen | THB 495,000 - 3,630,000+ | USD 15,000 - 110,000+ | Regional tertiary care may suit planned surgery or standard radiation for appropriate patients. | Include pathology, imaging, hormone supply, and urinary complication plans. |
| Hat Yai and Songkhla | THB 495,000 - 3,630,000+ | USD 15,000 - 110,000+ | Southern regional services can support selected urology and oncology pathways. | Ask about catheter problems, retention, infection, and emergency admission. |
| Nakhon Ratchasima | THB 495,000 - 3,300,000+ | USD 15,000 - 100,000+ | A large regional route may offer value for surgery, hormone injections, and follow-up. | A specialist referral for high-risk or metastatic disease should be documented. |
| Chiang Rai | THB 495,000 - 3,135,000+ | USD 15,000 - 95,000+ | Regional urology assessment is possible, with advanced imaging and therapies varying by center. | Confirm where PSMA imaging and radiation are performed. |
| Udon Thani | THB 478,500 - 3,135,000+ | USD 14,500 - 95,000+ | Planned urology procedures and stable treatment may be feasible in selected centers. | Clarify long-term hormone supply and PSA reporting. |
| Rayong | THB 495,000 - 3,465,000+ | USD 15,000 - 105,000+ | Eastern transport access can help selected planned prostate care. | Travel convenience should follow a complete treatment and recovery pathway. |
Estimate variables
Surveillance, localized cure, biochemical recurrence, hormone-sensitive spread, and resistant disease require different resources.
Ask the team to state treatment intent.
MRI, PSMA PET, biopsy review, genomic tests, node sampling, and stage work alter the decision and initial bill.
Do not compare a surgery quote with a fully staged plan.
Robotic system, open or laparoscopic access, brachytherapy, fiducials, spacer, and image guidance have different costs.
Name every device and consumable.
Injection interval, oral agent, chemotherapy, bone agent, radioligand, dose, and months of treatment drive recurring cost.
Request a six- or twelve-month scenario.
Catheter, incontinence, erectile dysfunction, bowel symptoms, infection, pelvic-floor therapy, and prosthetic treatment can add care.
Recovery should be priced as a separate phase.
Medical cost breakdown
PSA trend, examination, MRI, targeted or systematic biopsy, pathology, grade group, and tissue review.
MRI source images and pathology details improve review.
CT, bone scan, PSMA PET, MRI pelvis, or other imaging selected for risk and symptoms.
Ask what each scan will change.
Blood count, kidney and liver function, ECG, anesthesia review, urinary score, sexual function, and bone or metabolic baseline.
Some tests are repeated locally before treatment.
Anesthesia, operation, robotic or laparoscopic equipment, catheter, pathology, room, medicines, mobilization, and discharge review.
Ask about node dissection and unexpected conversion.
Simulation, fiducials, spacer, contouring, planning, physics checks, image guidance, fractions, and reviews.
Price the complete course rather than a daily rate only.
Hormone injection, drug administration, laboratory checks, infusion, chemotherapy, bone medicine, or observation.
Pharmacy supply and administration should be separate lines.
Catheter removal, urine leakage education, pelvic-floor training, wound care, pain control, and urinary review.
Retention, infection, or leak can change the stay.
Urinary frequency, bowel irritation, fatigue, erectile changes, medication, and follow-up review.
Ask who manages late symptoms.
PSA, testosterone, imaging, hormone side-effect care, bone health, cardiovascular review, and recurrence management.
Plan home testing before leaving Thailand.
Complete journey budget
Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.
PSA table, MRI, biopsy, grade group, scans, urinary and sexual scores, medicines, and hospital acceptance.
Include fertility or continence priorities.
Admission, catheter or radiation visits, housing, companion, transport, translation, medicines, and extra nights.
Radiation attendance may make a nearby room essential.
Fit-to-fly, catheter plan, PSA schedule, prescription supply, pelvic-floor rehabilitation, and urologist handover.
A treatment summary is needed before travel home.
Country access
Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.
Use Thailand Medical Hub and the hospital international department to confirm the urology, radiation, nuclear medicine, and oncology services.
Confirm robotic consumables, brachytherapy materials, PSMA imaging access, hormone products, and advanced medicines in writing.
Request the radiation oncologist, physicist, machine, planning process, image guidance, and backup schedule.
Agree release, courier, tissue review, translation, consent, records access, and return of slides or blocks.
Check the Thailand e-Visa portal or relevant embassy and allow for catheter, radiation, or treatment delays.
Hospital selection
Urologist, uropathologist, radiologist, radiation oncologist, medical oncologist, nuclear medicine, anesthetist, and rehabilitation.
Ask whether the case is discussed as one pathway.
MRI, biopsy review, grade group, node and margin reporting, PSMA PET or other stage imaging, and record transfer.
A high-risk decision needs complete evidence.
Robotic or laparoscopic system, radiation planning, brachytherapy, fiducials, spacer, and emergency urologic support.
Confirm what is actually onsite.
Catheter, continence, pelvic floor, erectile function, bowel symptoms, infection, pain, and psychosocial support.
Outcomes should be discussed without guarantees.
Hormone injections, oral drugs, PSA testing, scans, bone care, and home clinician communication.
Avoid a plan that ends at discharge.
Treating team
Interprets anatomy, chooses access, discusses nerve-sparing limits, removes the prostate when indicated, and manages urinary complications.
Reports grade, margins, nodes, extracapsular extension, seminal vesicles, and the findings that shape further treatment.
Plans external or implant radiation, image guidance, dose constraints, bladder and bowel preparation, and follow-up.
Manages hormone therapy, chemotherapy, advanced medicines, bone protection, and selected radioligand treatment.
Supports catheter care, continence, pelvic-floor strength, sexual recovery, nutrition, and safe activity.
Treatment timeline
Share PSA history, MRI, biopsy, grade group, stage scans, urinary and sexual function, medicines, and priorities.
The Thai team confirms stage, resectability, need for PSMA imaging, treatment intent, and options with expected trade-offs.
Surgery, radiation, brachytherapy, surveillance, or systemic treatment starts after consent and safety tests.
Catheter, wound, urinary, bowel, pain, hormone, or radiation reviews determine the next safe step.
Hormone injections, tablets, chemotherapy, scans, PSA, and side-effect support continue according to risk and response.
Receive operative and pathology reports, PSA and testosterone schedule, prescriptions, red flags, and clinician contacts.
Risks and edge cases
Catheter removal may be delayed, or infection, leak, bleeding, or a bladder-neck issue may need treatment.
Do not book a fixed flight immediately after catheter removal.
Leakage can persist and require pads, pelvic-floor therapy, medication, or further review.
Ask about rehabilitation after returning home.
Nerve injury, hormone therapy, age, baseline function, and treatment sequence can affect erections and fertility.
Discuss sperm preservation before treatment when relevant.
Frequency, bleeding, urgency, rectal symptoms, fatigue, or late tissue effects may require local care.
Know the treating team’s contact route.
Hot flashes, fatigue, bone loss, diabetes, cardiovascular risk, mood, and sexual changes need monitoring.
Long-term medicine and lab costs matter.
Rising PSA or new lesions may require imaging, biopsy, new medicines, radiation, or a changed goal.
No plan can guarantee a fixed duration.
Destination comparison
The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.
| Decision factor | India | Turkey | Thailand | How to use this |
|---|---|---|---|---|
| Urology network | Large metro and regional urology market with strong price variation and many robotic programs. | Established private and university urology services with international surgery packages. | International private services and public tertiary centers offer surgery, radiation, and systemic care. | Compare pathology, imaging, technique, rehabilitation, and medicine continuity. |
| Pricing pattern | Surgery, robotic fee, radiation, and medicines may be separate. | Package prices can be in TRY or foreign currency with variable inclusions. | THB estimates may separate operation, device, radiation, and ongoing hormone treatment. | Ask for the full first-year budget. |
| Regional option | Selected Tier 2 centers may provide surgery or follow-up with tertiary support. | Regional centers can suit selected localized disease. | Regional care may work for planned treatment if advanced imaging and referral are clear. | Choose for the complete pathway. |
| Continuity | Practical for South Asia, Gulf, and Africa. | Practical for Europe, Gulf, and Central Asia. | Practical for Southeast Asia and Asian routes. | Consider PSA, catheter, and medicine follow-up after travel. |
Decision guidance
The hospital confirms grade group, stage, treatment intent, technique, radiation or medicine access, and a home PSA plan.
The proposal offers robotic surgery without pathology review, hides hormone duration, ignores continence, or promises guaranteed sexual recovery.
The named urology team, pathology, imaging, emergency service, and referral link are sufficient for the risk group.
There is inability to pass urine, heavy bleeding, sepsis, severe bone pain with weakness, confusion, or rapidly worsening symptoms.
Reports for review
Prepare PSA values with dates, MRI source images and report, biopsy slides or report, grade group, stage imaging, urinary and sexual baseline, prior surgery or radiation, medicines, comorbidities, fertility goals, and a treatment timeline. Ask for a written Thai proposal naming intent, technique, device, radiation or drug phases, catheter and recovery plan, THB validity, complications, and PSA handover.
Upload medical reportsList every PSA with date, laboratory, treatment status, and any velocity or nadir information.
Send multiparametric MRI, targeted and systematic biopsy, grade group, cores, tumor volume, and pathology review.
Include CT, bone scan, PSMA PET, MRI, and reports showing nodes, bone, or other spread.
Document urinary symptoms, catheter history, erectile function, bowel disease, fertility, and prior pelvic treatment.
Include heart, diabetes, kidney, clotting, anesthesia, obesity, and medication information.
List alpha blockers, anticoagulants, hormone medicines, steroids, supplements, and allergies.
Share passport, visa, companion, mobility, catheter support, housing, language, and flexible return details.
Name urologist, oncologist, PSA laboratory, pelvic-floor therapist, and emergency hospital.
Ask whether access is open, laparoscopic, robotic, external radiation, or brachytherapy and what devices are used.
Request hormone, chemotherapy, bone, radioligand, or oral-drug names, dose, intervals, and expected months.
Confirm catheter, continence, erectile, bowel, pelvic-floor, and early review costs.
Agree PSA schedule, pathology, prescription, recurrence plan, privacy, cancellation, and emergency terms.
Common questions
Localized surgery may be around THB 495,000 to 1,155,000, radiation and hormone care around THB 825,000 to 2,310,000, and advanced disease can exceed THB 1,320,000 to 4,950,000.
Robotic access may offer benefits for selected patients and teams, but cancer control and recovery depend on anatomy, surgeon expertise, pathology, and follow-up.
Usually not. Hormone treatment is a separate phase unless the quotation names its drug, dose, interval, duration, and monitoring.
The hospital should decide based on catheter, urine, wound, pain, mobility, infection, and travel fitness; a fixed tourist schedule is not appropriate.
It may require multiple sessions or a longer stay, and hormone treatment may continue at home. Confirm the exact fraction schedule.
It can help stage higher-risk or recurrent disease when available and can alter the treatment plan, but the team decides whether it is clinically useful.
It can. Baseline function, nerve involvement, surgery, radiation, hormone treatment, age, and rehabilitation all influence recovery.
Often for selected stable care if PSA testing, medicine supply, urinary support, and a tertiary referral pathway are reliable.
The team may repeat PSA, imaging, or other assessment and consider salvage radiation, hormone treatment, or another systemic option.
Send PSA history, MRI, biopsy and grade group, scans, urinary and sexual baseline, prior treatment, medicines, and comorbidities.
Review and sources
The bands separate localized prostatectomy, radiation with hormone treatment, and recurrent or metastatic care because risk group and treatment duration drive the price. The working conversion is approximately THB 33 per USD using the Bank of Thailand source checked in July 2026. The estimate includes MRI and pathology review, PSMA or stage imaging, equipment, radiation, hormone supply, continence and sexual rehabilitation, housing, and PSA continuity. The treating hospital must issue the final estimate after reviewing the full record.
This page is educational and cannot diagnose prostate cancer, choose surveillance or treatment, guarantee continence or erections, or certify a hospital’s current authorization. A urology and oncology team should review the pathology, MRI, PSA, and stage. Urinary retention, heavy bleeding, sepsis, severe weakness, or rapidly worsening pain requires urgent local care.
National Cancer Institute, Thailand · Accessed 2026-07-19
Supports: Cancer service context.
National Cancer Institute, Thailand · Accessed 2026-07-19
Supports: Cancer registry context.
Thailand Medical Hub, Ministry of Public Health · Accessed 2026-07-19
Supports: International medical-care context.
Thailand Medical Hub, Ministry of Public Health · Accessed 2026-07-19
Supports: Provider verification context.
Healthcare Accreditation Institute, Thailand · Accessed 2026-07-19
Supports: Quality-certification context.
Bank of Thailand · Accessed 2026-07-19
Supports: THB and USD conversion context.
Royal Thai Government · Accessed 2026-07-19
Supports: Medical travel documentation context.
Related planning
Compare another Thailand oncology pathway.
Review a different cancer treatment sequence.
Compare complex treatment and surgery planning.
Review cycle-based systemic treatment costs.
Compare India city ranges.
Compare another international route.
Prepare PSA, MRI, and biopsy records.
Request an independent treatment review.
Plan medical travel paperwork.
Arrange PSA and recovery continuity.
Questions about an estimate? Email support@virellohealth.com.